Covid-19: Has the spread of omicron BA.2 made antibody treatments redundant?
The US Food and Drug Administration has removed its authorisation for anti-SARS-CoV-2 monoclonal antibody treatment…
Category: General practice / family medicine, UK, US, COVID-19